Logan Reed
The first polio vaccine was developed in 1952 by Jonas Salk and his team at the University of Pittsburgh, and it was licensed in the US in 1955. This marked a significant turning point in the fight against polio, which had been a major cause of disability and death worldwide. By the mid-20th century, the poliovirus could be found all over the world, and it killed or paralysed over half a million people annually. The development of the polio vaccine led to a rapid decline in cases, and by 1961, only 161 cases remained in the US. This success spurred global efforts to eradicate polio, with countries like Hungary, Czechoslovakia, and Cuba initiating nationwide immunisation programmes in the early 1960s. In the US, childhood vaccination initiatives were launched to increase immunisation rates, and by the 1980s, vaccination levels among school-going children had risen significantly. By 1998-1999, all but four US states mandated polio vaccination for students from kindergarten through 12th grade. Today, polio has been eliminated from most parts of the world, with only a handful of countries still reporting endemic cases.
| Characteristics | Values |
|---|---|
| Year the polio vaccine was first developed | 1952 |
| Year the polio vaccine was first licensed | 1955 |
| Year the polio vaccine was first administered | 1955 |
| Year the OPV was first administered | 1962 |
| Year polio was eliminated in the Americas | 1994 |
| Year polio was eliminated in the Western Pacific | 2000 |
| Year wildtype 2 polio was eradicated | 1999 |
| Year wildtype 3 polio was eradicated | 2020 |
| Year polio vaccination levels rose to 96% in the US | 1980 |
| Year all but four US states had vaccine mandates for students entering kindergarten through 12th grade | 1998-1999 |
Explore related products
What You'll Learn
- The first polio vaccine was developed in 1952 and licensed in 1955
- By 1994, polio had been eliminated from the Americas
- In 1995, mass vaccination campaigns took place in China and India
- The U.S. has vaccine-related laws for children before they enter school
- The inactivated polio vaccine (IPV) is the only vaccine given to prevent polio in the U.S
The first polio vaccine was developed in 1952 and licensed in 1955
The first polio vaccine was developed in 1952 by Jonas Salk and a team at the University of Pittsburgh. This initial vaccine required years of subsequent testing. Salk reported a successful test on a small group of adults and children in 1953, and the results were published in JAMA. A key laboratory technique was invented by Leone N. Farrell, which enabled the mass production of the vaccine by a team she led in Toronto. Salk's vaccine was then used in the Francis Field Trial, the largest medical experiment in history at that time. The test began with about 4,000 children and eventually involved 1.8 million children in 44 states.
The first polio vaccine was licensed in the U.S. in 1955, and it arrived at the Mayo Clinic on April 13, one day after its licensing. This vaccine was an inactivated polio vaccine (IPV) developed by Dr. Jonas E. Salk and his colleagues. By 1957, annual cases of polio in the U.S. dropped from 58,000 to 5,600, and by 1961, only 161 cases remained.
Salk was committed to equitable access to his vaccine and understood that elimination efforts would require universal low- or no-cost vaccination. He did not profit from sharing the formulation or production processes. Six pharmaceutical companies were licensed to produce IPV. Albert Sabin later developed a second type of polio vaccine, the oral polio vaccine (OPV), which became widely available and supplanted Salk's injected vaccine. OPV had the added benefit of interrupting the chain of transmission, meaning it could stop polio outbreaks in their tracks.
In the U.S., vaccination initiatives have aimed to increase the number of vaccinated children. By 1980, vaccination levels among children going to school for the first time had risen. By 1998-1999, all but four U.S. states had vaccine requirements for students entering kindergarten through 12th grade. However, many states allow religious or philosophical exemptions from vaccine requirements.
Smallpox Vaccination: The US History and End Date
You may want to see also
Explore related products
By 1994, polio had been eliminated from the Americas
The first effective polio vaccine was developed in 1952 by Jonas Salk and a team at the University of Pittsburgh. Salk's injectable vaccine was announced safe to use in 1955, and a nationwide immunisation campaign began in the United States. The results were remarkable, with annual cases dropping from 58,000 to 5,600 by 1957, and to just 161 cases by 1961.
In 1961, Albert Sabin developed a second polio vaccine, an oral vaccine (OPV) that was easier to administer and greatly facilitated distribution. This vaccine was licensed in the US in 1963 and was soon adopted in several countries. In 1962, Cuba began using the oral vaccine in nationwide polio campaigns, and in 1960, Czechoslovakia became the first country to scientifically demonstrate nationwide eradication of poliomyelitis.
In the 1980s, the Pan American Health Organization (PAHO), led by Dr Ciro de Quadros, began to mobilise support from health authorities to eradicate polio in the Americas. PAHO launched an initiative to achieve this goal in 1985, and in 1994, the Region of the Americas became the first in the world to be certified polio-free by the World Health Organization (WHO). This was due to the concerted efforts of thousands of health workers, vaccinators, epidemiologists, and the immunization team at PAHO.
Vaccine Reactions: What Do They Mean?
You may want to see also
Explore related products
In 1995, mass vaccination campaigns took place in China and India
In the mid-20th century, the poliovirus was widespread and deadly, affecting people worldwide and killing or paralysing over half a million people annually. The first effective polio vaccine was developed in 1952 by Jonas Salk and his team at the University of Pittsburgh. This vaccine was licensed in 1955, and by 1961, polio cases in the US had dropped to 161 from 58,000.
India also had experience with vaccine production, with significant capacity developed in the country with the assistance of the World Health Organization (WHO). The mass vaccination campaigns in China and India in 1995 were part of a broader effort to eradicate polio globally. In 1988, the World Health Assembly passed a resolution to eradicate polio, and the Global Polio Eradication Initiative (GPEI) was launched. By 1994, polio had been eliminated from the Americas, and by 2000, the Western Pacific region was polio-free.
The oral polio vaccine (OPV), developed by Albert Sabin, played a crucial role in these mass vaccination campaigns. OPV had the advantage of interrupting the chain of transmission, preventing polio outbreaks. This made it ideal for mass vaccination campaigns, and it was used in nationwide immunization programmes in Hungary, Czechoslovakia, and Cuba in the early 1960s, helping these countries become the first to eliminate polio.
Immunity: Diseases That Don't Confer Protection
You may want to see also
Explore related products
The U.S. has vaccine-related laws for children before they enter school
In the United States, vaccine-related laws for children vary from state to state. However, every state has laws that require children to receive certain vaccines before entering school or daycare. These laws aim to protect children and communities from contagious diseases. While the specific vaccines mandated may differ, some commonly required vaccinations include:
- Polio vaccine
- Diphtheria and Tetanus toxoid-containing vaccine
- Pertussis vaccine (DTaP or Tdap)
The timing of vaccine doses is also specified. For example, in the case of the polio vaccine, the first dose is typically given shortly after birth, between 1 and 2 months of age, followed by a second dose at 4 months. The third dose is administered between 6 and 18 months, and a booster vaccination is given at 4 to 6 years of age, ensuring completion before school entry.
While these vaccine laws are in place, parents may have the option to opt out of specific vaccines for their children due to valid medical, religious, or personal reasons, depending on the state. Medical exemptions are typically granted when a child has a medical condition or takes medication that weakens their immune system, has a severe allergy to a vaccine or its ingredients, or has experienced a serious reaction to a vaccine in the past. Religious exemptions are also considered in certain states, balancing individual rights with the need to safeguard public health.
Meningitis Vaccine: Know the Name, Protect Yourself
You may want to see also
Explore related products
The inactivated polio vaccine (IPV) is the only vaccine given to prevent polio in the U.S
Before the polio vaccine was available, several polio epidemics occurred between 1948 and 1955. The disease was a major cause of disability in children, with about 16,000 cases of polio occurring each year in the US in the 20th century. The first effective polio vaccine was developed in 1952 by Jonas Salk and his team at the University of Pittsburgh. The vaccine was licensed in the US on 12 April 1955, and by 1961, only 161 cases remained.
In 1955, an oral polio vaccine (OPV) was developed by Albert Sabin. OPV was given by mouth as a liquid and contained a weakened live vaccine. While OPV was effective in interrupting the chain of transmission, it was discontinued in the US due to the rare risk of causing polio in unvaccinated individuals or those with weakened immune systems.
The inactivated polio vaccine (IPV) is the only vaccine currently recommended for routine immunization in the US. IPV has been administered since 1999, when the US adopted an IPV-only schedule, removing OPV. IPV is safe and proven to help fight off polio, and it can be administered to immunocompromised individuals or those with close contact with immunocompromised individuals. It is recommended that children receive four doses of IPV, with the first dose given shortly after birth, usually between 1 and 2 months of age, and a booster vaccination at 4 to 6 years of age. In some cases, a fifth vaccination may be given during adolescence.
For adults, the Advisory Committee on Immunization Practices (ACIP) has recommended that all individuals aged 18 and older who are known or suspected to be unvaccinated or incompletely vaccinated against polio complete a primary polio vaccination series with IPV. This recommendation was issued in June 2023, underscoring the ongoing risk of poliovirus importation into the US. Fully vaccinated adults at increased risk of exposure may also receive a single lifetime booster dose of IPV.
Pneumococcal Vaccination: PCV21's Key Advantage
You may want to see also
Frequently asked questions
The first effective polio vaccine was developed in 1952 by Jonas Salk and a team at the University of Pittsburgh. It was licensed in 1955.
By 1998-1999, all but four US states had vaccine requirements (mandates) for students entering kindergarten through 12th grade.
The polio vaccine is a vaccine that helps to prevent the spread of the poliovirus, which can cause paralysis and death.
There are two types of polio vaccines: the inactivated polio vaccine (IPV) and the oral polio vaccine (OPV).
While I cannot find a comprehensive list of countries that have made the polio vaccine mandatory for school, I can tell you that by 1998-1999, 46 out of 50 US states had vaccine requirements for students.
